Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee keeps continuous glucose monitor coverage bill under study after lengthy testimony from family members and insurers
Summary
Members asked the insurance department for a financial impact study on how a CGM coverage mandate would affect individual and small‑group premiums and deductibles; sponsors and family members urged broader access for Type 1 patients.
The Commerce and Consumer Affairs committee retained a bill on continuous glucose monitors (CGMs) for interim study after extended testimony from sponsors, medical‑policy commenters and family members of people with Type 1 diabetes.
Representative Spear, the sponsor present for the item, described the goal as reducing access barriers to CGMs because continuous monitoring can prevent progression to insulin therapy in some patients and improve glucose control, especially for juvenile onset patients.…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
